J.Jill (JILL) Issues Q1 Earnings Guidance

Share on StockTwits

J.Jill (NYSE:JILL) issued an update on its first quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.21-0.23 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.28. The company issued revenue guidance of flat to down 2% to $177.5-181.5 million, compared to the consensus revenue estimate of $185.56 million.J.Jill also updated its FY 2019 guidance to $0.66-0.70 EPS.

JILL opened at $7.04 on Friday. The company has a quick ratio of 0.91, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $265.99 million, a PE ratio of 7.60, a price-to-earnings-growth ratio of 0.80 and a beta of 1.91. J.Jill has a 12 month low of $4.17 and a 12 month high of $9.62.

J.Jill (NYSE:JILL) last posted its quarterly earnings results on Wednesday, March 6th. The specialty retailer reported $0.05 EPS for the quarter, beating the consensus estimate of $0.03 by $0.02. The business had revenue of $170.90 million during the quarter, compared to analysts’ expectations of $170.91 million. J.Jill had a return on equity of 18.02% and a net margin of 7.98%. The company’s quarterly revenue was down 9.4% compared to the same quarter last year. During the same period last year, the firm earned $0.13 EPS. As a group, research analysts forecast that J.Jill will post 0.71 EPS for the current fiscal year.

The firm also recently declared a special dividend, which will be paid on Monday, April 1st. Stockholders of record on Tuesday, March 19th will be issued a $1.15 dividend. The ex-dividend date is Monday, March 18th.

JILL has been the subject of several research reports. Jefferies Financial Group reaffirmed a buy rating and set a $9.00 price objective on shares of J.Jill in a report on Thursday, November 15th. Zacks Investment Research cut J.Jill from a hold rating to a sell rating in a report on Saturday, November 17th. Morgan Stanley reduced their price objective on J.Jill from $7.50 to $7.00 and set an equal weight rating for the company in a report on Thursday, November 29th. Finally, Wells Fargo & Co reduced their price objective on J.Jill from $7.00 to $6.00 and set a market perform rating for the company in a report on Wednesday, January 2nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. J.Jill presently has an average rating of Hold and a consensus price target of $6.86.

A hedge fund recently raised its stake in J.Jill stock. Geode Capital Management LLC grew its stake in shares of J.Jill Inc (NYSE:JILL) by 5.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 153,468 shares of the specialty retailer’s stock after buying an additional 8,231 shares during the period. Geode Capital Management LLC owned 0.35% of J.Jill worth $817,000 at the end of the most recent reporting period. 24.75% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “J.Jill (JILL) Issues Q1 Earnings Guidance” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/4206106/j-jill-jill-issues-q1-earnings-guidance.html.

About J.Jill

J.Jill, Inc operates as an Omni channel retailer women's apparel under the J.Jill brand name in the United States. The company offers knit and woven tops, bottoms, and dresses, as well as sweaters and outerwear; and complementary footwear and accessories, including scarves, jewelry, and hosiery for misses, petites, and women.

Recommended Story: Earnings Per Share (EPS)

Earnings History and Estimates for J.Jill (NYSE:JILL)

Receive News & Ratings for J.Jill Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for J.Jill and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Amerisafe  Downgraded by BidaskClub
Amerisafe Downgraded by BidaskClub
Zacks Investment Research Lowers Pieris Pharmaceuticals  to Hold
Zacks Investment Research Lowers Pieris Pharmaceuticals to Hold
BMO Capital Markets Trims Biogen  Target Price to $250.00
BMO Capital Markets Trims Biogen Target Price to $250.00
Axonics Modulation Technologies  vs. NuVasive  Head to Head Review
Axonics Modulation Technologies vs. NuVasive Head to Head Review
Comparing BlackBerry  & ServiceNow
Comparing BlackBerry & ServiceNow
$2.20 Billion in Sales Expected for Autoliv Inc.  This Quarter
$2.20 Billion in Sales Expected for Autoliv Inc. This Quarter


© 2006-2019 Ticker Report